101 related articles for article (PubMed ID: 4919553)
1. Haemodynamic studies with peruvoside in human congestive heart failure.
Bhatia ML; Manchanda SC; Roy SB
Br Med J; 1970 Sep; 3(5725):740-3. PubMed ID: 4919553
[TBL] [Abstract][Full Text] [Related]
2. A preliminary report on a clinical trial of peruvoside--a new cardiac glycoside.
Dalal NJ; Billimoria AR; Vakil NJ; Shah SJ
Indian Heart J; 1972 Apr; 24(2):129-33. PubMed ID: 4637593
[No Abstract] [Full Text] [Related]
3. Observations on the effects of peruvoside.
Raizada V; Padmavati S
Indian J Med Res; 1971 Feb; 59(2):271-5. PubMed ID: 5579241
[No Abstract] [Full Text] [Related]
4. [Action of actodigin (AY-22,241) in patients with cardiac insufficiency and chronic auricular fibrillation or flutter].
Bojorges R; Cárdenas M; Pastelín G; Mendez R
Arch Inst Cardiol Mex; 1974; 44(4):615-23. PubMed ID: 4847978
[No Abstract] [Full Text] [Related]
5. [The treatment of cardiac insufficiency of varying genesis with a new cardiac glycoside].
Gill E
Med Welt; 1970 Aug; 34():1472-6. PubMed ID: 5510409
[No Abstract] [Full Text] [Related]
6. Clinical and haemodynamic studies with peruvoside (Cd. 421) in congestive heart failure.
Bhatia ML; Manchanda SS; Gupta SP; Roy SB
Indian Heart J; 1971 Apr; 23(2):159-63. PubMed ID: 5154111
[No Abstract] [Full Text] [Related]
7. Comparison of a partially synthetic glycoside strophanthidin-arabinoside with ouabain and digitalis in patients with auricular fibrillation.
Gold H; Greiner T; Zahm W; Chen KK
J Clin Pharmacol J New Drugs; 1970; 10(3):145-52. PubMed ID: 5266629
[No Abstract] [Full Text] [Related]
8. Pharmacological evaluation of peruvoside, a new cardiac glycoside from Thevetia neriifolia with a note on its clinical trials in patients with congestive heart failure.
Arora RB; Sharma JN; Bhatia ML
Indian J Exp Biol; 1967 Jan; 5(1):31-6. PubMed ID: 6036987
[No Abstract] [Full Text] [Related]
9. [Studies on the effect of peruvoside on heart function in animal experiments].
Schorscher E; Sommer S; Wild AJ; Block A
Arzneimittelforschung; 1968 Dec; 18(12):1582-90. PubMed ID: 5756257
[No Abstract] [Full Text] [Related]
10. Pharmacological studies on peruvoside--a new cardiac glycoside from Thevetia neriifolia Juss.
KOHLI JD; VOHRA MM
Arch Int Pharmacodyn Ther; 1960 Jul; 126():412-25. PubMed ID: 14410550
[No Abstract] [Full Text] [Related]
11. A quantitative comparison of the cardiac actions of peruvoside with those of G-strophanthin and proscillaridin.
Imai S; Katano Y; Takeda K; Kumada M; Iizuka H
Tohoku J Exp Med; 1972 Dec; 108(4):389-99. PubMed ID: 4677118
[No Abstract] [Full Text] [Related]
12. [Clinical trial of a new cardiac glycoside: cd.412].
Gentile C; Gentile JH
Prensa Med Argent; 1972 Jun; 59(22):841-8. PubMed ID: 5051118
[No Abstract] [Full Text] [Related]
13. [Cardiac glycoside therapy of congestive heart failure. II].
Tomov I
Vutr Boles; 1981; 20(1):1-9. PubMed ID: 7245720
[No Abstract] [Full Text] [Related]
14. The effects of reserpine and propranolol on the therapeutic and toxic effects of peruvoside in the heart-lung preparation and intact dogs.
Arora RB; Bagchi N; Gupta OP
Indian J Med Res; 1972 Jan; 60(1):143-52. PubMed ID: 5029118
[No Abstract] [Full Text] [Related]
15. Mechanism of peruvoside-induced emesis.
Gaitonde BB; Joglekar SN
Neuropharmacology; 1972 May; 11(3):427-33. PubMed ID: 5065716
[No Abstract] [Full Text] [Related]
16. Systolic time intervals in constrictive pericarditis. A study before and after digitalis.
Bhatia ML; Manjuran RJ
Br Heart J; 1975 Nov; 37(11):1176-83. PubMed ID: 1191433
[TBL] [Abstract][Full Text] [Related]
17. [Acedoxin treatment of patients with circulatory insufficiency].
Savenkov PM; Martynov AI; Zadionchenko VS; Bart BIa
Kardiologiia; 1968 Sep; 8(9):102-6. PubMed ID: 5728492
[No Abstract] [Full Text] [Related]
18. Role of catecholamines in the central mechanism of emetic response induced by peruvoside and ouabain in cats.
Gaitondé BB; Joglekar SN
Br J Pharmacol; 1975 Jun; 54(2):157-62. PubMed ID: 1148505
[TBL] [Abstract][Full Text] [Related]
19. [Peruvoside in clinical practice. Study of a new cardioactive drug in cardiac insufficiency].
Verga L; Alazn R
Minerva Cardioangiol; 1975 Jan; 23(1):43-7. PubMed ID: 1143647
[No Abstract] [Full Text] [Related]
20. The role of the sugar component in cardiac glycosides on their action in patients with auricular fibrillation and congestive failure.
Gold H; Kwit NT; Shane SJ; Dayrit C
J Clin Pharmacol J New Drugs; 1969; 9(3):148-54. PubMed ID: 5255179
[No Abstract] [Full Text] [Related]
[Next] [New Search]
